HBIO
Price:
$6.08
Market Cap:
$27.42M
Harvard Bioscience, Inc. (HBIO) is a global provider of cutting-edge technologies, products, and services crucial for fundamental scientific investigation, drug discovery, and preclinical testing. Serving both domestic and international markets, the company supplies an extensive range of cellular and molecular instruments. This includes precision fluid handling devices like syringe and peristaltic pumps, alongside a variety of tools and accessories for tissue and organ-based laboratory research, such as surgical instruments, infusion systems, and behavioral analysis setups. Their portfolio also encompasses analytical equipment like spectrophotometers, microplate readers, amino acid analyzers...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2001-03-19
Stock Exchange
NASDAQ
Ticker
HBIO
According to Harvard Bioscience, Inc.’s latest financial reports and current stock price. The company's current ROE is -73.04%. This represents a change of 274.24% compared to the average of -19.52% of the last 4 quarters.
The mean historical ROE of Harvard Bioscience, Inc. over the last ten years is -47.78%. The current -73.04% ROE has changed 52.87% with respect to the historical average. Over the past ten years (40 quarters), HBIO's ROE was at its highest in in the June 2022 quarter at 3.14%. The ROE was at its lowest in in the March 2025 quarter at -339.33%.
Average
-47.78%
Median
-5.85%
Minimum
-412.84%
Maximum
-0.35%
Discovering the peaks and valleys of Harvard Bioscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.72%
Maximum Annual ROE = -0.35%
Minimum Annual Increase = -96.61%
Minimum Annual ROE = -412.84%
| Year | ROE | Change |
|---|---|---|
| 2025 | -412.84% | 2.01% |
| 2024 | -19.58% | 319.07% |
| 2023 | -4.67% | -64.53% |
| 2022 | -13.18% | 3.72% |
| 2021 | -0.35% | -96.61% |
| 2020 | -10.19% | 77.52% |
| 2019 | -5.74% | 36.20% |
| 2018 | -4.21% | 293.98% |
| 2017 | -1.07% | -82.08% |
| 2016 | -5.97% | -75.69% |
The current ROE of Harvard Bioscience, Inc. (HBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-145.70%
5-year avg
-90.12%
10-year avg
-47.78%
Harvard Bioscience, Inc.’s ROE is greater than NEXGEL, Inc. (-70.23%), greater than Retractable Technologies, Inc. (-8.45%), greater than Femasys Inc. (-258.08%), greater than Nexalin Technology, Inc. (-191.88%), greater than Sonnet BioTherapeutics Holdings, Inc. (-518.10%), greater than TAO Synergies Inc. (-120.29%), greater than NuCana plc (-153.80%), greater than Cosmos Health Inc. (-96.48%), greater than CollPlant Biotechnologies Ltd. (-160.28%),
| Company | ROE | Market cap |
|---|---|---|
| -70.23% | $5.08M | |
| -8.45% | $20.95M | |
| -258.08% | $12.62M | |
| -191.88% | $8.87M | |
| -518.10% | $8.43M | |
| -120.29% | $11.90M | |
| -153.80% | $11.84M | |
| -96.48% | $13.04M | |
| -160.28% | $4.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harvard Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Harvard Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Harvard Bioscience, Inc.'s ROE?
How is the ROE calculated for Harvard Bioscience, Inc. (HBIO)?
What is the highest ROE for Harvard Bioscience, Inc. (HBIO)?
What is the 3-year average ROE for Harvard Bioscience, Inc. (HBIO)?
What is the 5-year average ROE for Harvard Bioscience, Inc. (HBIO)?
How does the current ROE for Harvard Bioscience, Inc. (HBIO) compare to its historical average?